Hummingbird Bioscience’s $25 Million Series B Funding Round

Dechert advised SK Holdings Co., Ltd. on the deal. Hummingbird Bioscience has closed an extended Series B funding round of US$25 million. This brings the total…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here